Singapore Office Of IDA Ireland

For any company expanding its international footprint, Europe is an obvious destination. For Singapore headquartered companies, Ireland has the advantage of being English-speaking, as well as being a committed member of the European Union. This makes it the ideal launchpad into the European market, for business growth and customer operations, world-class manufacturing, or research, development and innovation.

Singapore Office

IDA Ireland
#13-04, Cross Street Exchange, 18 Cross Street,
Singapore
048423

+65 6238 0774

philip.dunne@ida.ie

Success Stories: Hear from leaders calling Ireland home

A proven path

See all Success Stories

Gene therapy startup chooses Ireland for commercial-scale manufacturing

MeiraGTx’s Shannon facility is unique, not only in Ireland but globally, as it streamlines gene therapy development, testing and manufacturing capabilities together in-house. This significantly reduces the time to patients for advanced therapeutic products, with months or potentially years saved.” -

Pharma giant’s 60-year history of investing in Ireland

The NGSC in Dublin is Novartis’s leading digital science centre globally. This is due to the fact that there is such a large amount of digital talent and a significant tech ecosystem in Ireland... We have an innovative team of data scientists and data managers who are harnessing the power of digital to revolutionise the way that we manage disease and ultimately get our medicines to patients faster.

Dublin site is a regional hub for product development

Dublin is such a hub for big tech companies that you might think ‘if we come to Dublin, we’re going to be competing with all of them, we won't be able to get good staff’. But I think the opposite is true. Because we’ve got such a base of well recognised brands in Dublin, that actually brings qualified people from all over Europe here.

Ireland is home to Stryker’s European Operations headquarters

Stryker's presence in Ireland is more than just a business expansion; it's a journey of mutual growth, skills development, and technological innovation that helps position Ireland as a global hub for leading innovation in the medical technology industry.

Ireland’s robust regulatory landscape a key factor

We are a steward of the assets of 50 million clients around the world. What’s important to them is that we are a trusted organisation, and the products and services that we offer are trusted. The UCITS framework, as overseen by the Central Bank of Ireland, has the interests of investors at heart. What Ireland offers is a robust and retail-oriented regulatory framework aligned to what we want to offer to our clients.

1500 employees across three sites in Ireland (Limerick, Cork and Dublin)

Since 1976, Ireland has been a critical innovation centre for ADI, thanks to its strong academic and research organisations, business ecosystem, and progressive government leadership. This next-generation semiconductor manufacturing facility and expanded R&D team will further extend ADI Limerick’s global influence.